Post-earnings recap
Reported
Wed, Jul 20, 2022
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported a strong earnings per share, beating expectations significantly. However, the stock declined by 1.55% following the announcement. This reaction may indicate investor concerns or uncertainty despite the positive EPS surprise.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.43 | N/A | +34.15% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—